What we're reading, December 21, 2016: researchers are racing to download Obamacare data before Donald Trump takes office; tens of millions of Americans import prescriptions illegally; and 4 more criminal charges in Flint water crisis.
Before President-elect Donald J. Trump takes office, researchers are racing to download data on the Affordable Care Act (ACA). POLITICO reported that researchers, and the White House, are worried Trump will remove the data that has been gathered so far from public sites. Democrats may need ACA data to build a case to keep parts of it, but the data can also be crucial for other efforts to reform the healthcare industry. The frenzy to copy healthcare data increased following reports that climate researchers were doing the same. Republicans have dismissed concerns that access to ACA data will end after Trump takes office.
With prices of medications rising in the United States, residents are looking outside the borders to import cheaper prescriptions. According to Kaiser Health News, tens of millions of Americans are illegally buying prescriptions online or while traveling abroad and importing them into the United States because they may cost half or less. And while these medications may be inferior, expired, or counterfeits, they are often the same ones available in the United States. The practice of importing medicine for personal use is illegal, but the law isn’t rigorously enforced.
In Michigan, 4 additional criminal charges have been filed related to the water crisis in Flint. Two of the individuals are former state-appointed emergency managers, and they could face decades in prison, reported The Washington Post. The yearlong investigation determined that the 2 conspired with 2 other Flint employees to enter a contract even though they were told repeatedly that the water plant was not in condition to deliver safe drinking water. There have now been 43 criminal charges filed against 13 current and former state and local officials.
Brodalumab Is Effective, Safe in Patients With Moderate to Severe Psoriasis
March 18th 2024Posters presented at the American Academy of Dermatology Annual Meeting demonstrated both short- and long-term efficacy and safety profiles of brodalumab in patients with moderate to severe psoriasis.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
AstraZeneca joins efforts to address high drug prices by capping out-of-pocket costs for its inhalers; Opill, the first OTC birth control pill, is now accessible through online sales; expansion prompts questions on the effectiveness and regulation of remote monitoring technology.
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Health Equity and Access Weekly Roundup: March 16, 2024
March 16th 2024This week, the Center on Health Equity and Access highlighted expert opinions on a mental health paradigm shift in the workplace, the impact health care algorithms can have on patient outcomes, and social factors linked with hidradenitis suppurativa severity, in addition to addressing the health needs of justice-involved populations.
Read More